Annovis Bio, Inc. (ANVS)

NYSE: ANVS · Real-Time Price · USD

1.210

+0.040 (3.42%)

At close: Oct 9, 2026, 4:00 PM EDT

1.200

-0.010 (-0.83%)

After-hours: Oct 9, 2026, 7:45 PM EDT

Annovis Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	52	92	69	192	110	142
Market Cap Growth	16.55%	32.13%	-63.84%	75.03%	-23.01%	174.06%
Enterprise Value	33	76	57	186	78	95
Last Close Price	1.21	3.46	5.03	18.70	13.43	17.58

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PB Ratio	-	5.44	7.46	-24.76	3.87	3.20
P/TBV Ratio	-	5.44	7.46	-	3.87	3.20

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Debt / Equity Ratio	4.40	-1.16	-1.13	0.74	-1.00	-1.03
Quick Ratio	2.95	5.37	2.72	1.35	3.69	30.33
Current Ratio	3.47	5.80	3.59	2.39	4.68	30.54
Return on Equity (ROE)	-703.68%	-220.61%	-3159.09%	-546.40%	-69.57%	-55.68%
Return on Assets (ROA)	-142.36%	-106.03%	-138.26%	-121.77%	-38.88%	-33.58%
Return on Capital Employed (ROCE)	-315.90%	-170.20%	-265.80%	-759.60%	-90.10%	-32.70%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-96.06%	-31.47%	-35.43%	-29.29%	-23.10%	-10.17%
Buyback Yield / Dilution	-73.71%	-67.97%	-35.60%	-10.55%	-7.03%	-20.88%

SEC Filings: 10-K · 10-Q